All research papers

Predicting VMAT patient-specific QA results using a support vector classifier trained on treatment plan characteristics and linac QC metrics.

Preparation of Zirconium-89 Solutions for Radiopharmaceutical Purposes: Interrelation Between Formulation, Radiochemical Purity, Stability and Biodistribution.

99mTc activity concentrations in room air and resulting internal contamination of medical personnel during ventilation-perfusion lung scans.

Stereotactic ablative radiotherapy versus standard of care palliative treatment in patients with oligometastatic cancers (SABR-COMET): a randomised, phase 2, open-label trial.

⁶⁸Ga-radiolabeled bombesin-conjugated to trimethyl chitosan-coated superparamagnetic nanoparticles for molecular imaging: preparation, characterization and biological evaluation.

Technical design and concept of a 0.35 T MR-Linac.

Implementing safe and robust Total Marrow Irradiation using Helical Tomotherapy - A practical guide.

⁶⁸Ga-FAPI PET/CT: Tracer Uptake in 28 Different Kinds of Cancer.

Safety and Efficacy of a Five-Fraction Stereotactic Body Radiotherapy Schedule for Centrally Located Non-Small-Cell Lung Cancer: NRG Oncology/RTOG 0813 Trial.

Adaptive radiotherapy: The Elekta Unity MR-linac concept.

Dosimetric Effect of Rotational Setup Errors in Single-Isocenter Volumetric-Modulated Arc Therapy of Multiple Brain Metastases.

Using adaptive magnetic resonance image-guided radiation therapy for treatment of inoperable pancreatic cancer.

Controversies, Consensus, and Collaboration in the Use of ¹³¹I Therapy in Differentiated Thyroid Cancer: A Joint Statement from the American Thyroid Association, the European Association of Nuclear Medicine, the Society of Nuclear Medicine and Molecular Imaging, and the European Thyroid Association.

Role of On-Table Plan Adaptation in MR-Guided Ablative Radiation Therapy for Central Lung Tumors.

Two StereoTactic ablative radiotherapy treatments for localized prostate cancer (2STAR): Results from a prospective clinical trial.

Development of Fibroblast Activation Protein-Targeted Radiotracers with Improved Tumor Retention.

MR-based treatment planning in radiation therapy using a deep learning approach.

AlignRT® and Catalyst™ in whole-breast radiotherapy with DIBH: Is IGRT still needed?

New fluoroethyl phenylalanine analogues as potential LAT1-targeting PET tracers for glioblastoma.

Gallium-68 Prostate-specific Membrane Antigen Positron Emission Tomography in Advanced Prostate Cancer-Updated Diagnostic Utility, Sensitivity, Specificity, and Distribution of Prostate-specific Membrane Antigen-avid Lesions: A Systematic Review and Meta-analysis.

Frameless Fractionated Gamma Knife Radiosurgery with ICON™ for Large Metastatic Brain Tumors.

Stereotactic ablative radiotherapy versus standard radiotherapy in stage 1 non-small-cell lung cancer (TROG 09.02 CHISEL): a phase 3, open-label, randomised controlled trial.

Monte Carlo dose verification for a single-isocenter VMAT plan in multiple brain metastases.

Addition of radium-223 to abiraterone acetate and prednisone or prednisolone in patients with castration-resistant prostate cancer and bone metastases (ERA 223): a randomised, double-blind, placebo-controlled, phase 3 trial.

Radionuclide intake risks in the clinical administration of ²²³RaCl₂.

Feasibility of stereotactic radiotherapy using a 1.5 T MR-linac: Multi-fraction treatment of pelvic lymph node oligometastases.

Personal Radiation Protection and Corresponding Dosimetry in Interventional Radiology: An Overview and Future Developments.

Feasibility and accuracy of quantitative imaging on a 1.5 T MR-linear accelerator.

Optimization of skin dose using in-vivo MOSFET dose measurements in bolus/non-bolus fraction ratio: A VMAT and a 3DCRT study.

Development and dosimetry of ²⁰³Pb/²¹²Pb-labelled PSMA ligands: bringing "the lead" into PSMA-targeted alpha therapy?

A Noninvasive Method to Reduce Radiotherapy Positioning Error Caused by Respiration for Patients With Abdominal or Pelvic Cancers.

Comparison of geometrical uncertainties in the radiotherapy for various treatment sites with two different immobilization marking methods.

Phase I/II Trial of Electrophysiology-Guided Noninvasive Cardiac Radioablation for Ventricular Tachycardia.

Clinical implementation of magnetic resonance imaging guided adaptive radiotherapy for localized prostate cancer.

MRI commissioning of 1.5T MR-linac systems - a multi-institutional study.

Deep learning for patient-specific quality assurance: Identifying errors in radiotherapy delivery by radiomic analysis of gamma images with convolutional neural networks.

MRI visibility of gold fiducial markers for image-guided radiotherapy of rectal cancer.

Poor Outcomes for Patients with Metastatic Castration-resistant Prostate Cancer with Low Prostate-specific Membrane Antigen (PSMA) Expression Deemed Ineligible for ¹⁷⁷Lu-labelled PSMA Radioligand Therapy.

First in-human radiation dosimetry of the gastrin-releasing peptide (GRP) receptor antagonist ⁶⁸Ga-NODAGA-MJ9.

EPID-based in vivo dosimetry using Dosimetry Check™: Overview and clinical experience in a 5-yr study including breast, lung, prostate, and head and neck cancer patients.

Assessment of motion error for frame-based and noninvasive mask-based fixation using the Leksell Gamma Knife Icon radiosurgery system.

Targeted Alpha Therapy, an Emerging Class of Cancer Agents: A Review.

Personalized ¹⁷⁷Lu-octreotate peptide receptor radionuclide therapy of neuroendocrine tumours: initial results from the P-PRRT trial.

Safety and efficacy of targeted alpha therapy with ²¹³Bi-DOTA-substance P in recurrent glioblastoma.

Treatment Outcome, Toxicity, and Predictive Factors for Radioligand Therapy with ¹⁷⁷Lu-PSMA-I&T in Metastatic Castration-resistant Prostate Cancer.

Exploring the prevalence and experience of mask anxiety for the person with head and neck cancer undergoing radiotherapy.

Delta radiomics for rectal cancer response prediction with hybrid 0.35 T magnetic resonance-guided radiotherapy (MRgRT): a hypothesis-generating study for an innovative personalized medicine approach.

Somatostatin receptor PET ligands - the next generation for clinical practice.

Stereotactic MR-Guided Online Adaptive Radiation Therapy (SMART) for Ultracentral Thorax Malignancies: Results of a Phase 1 Trial.

Treatment plan complexity does not predict IROC Houston anthropomorphic head and neck phantom performance.

Clinical outcomes of image-guided proton therapy for histologically confirmed stage I non-small cell lung cancer.

Dosimetry of ¹⁷⁷Lu-PSMA-617 in Metastatic Castration-Resistant Prostate Cancer: Correlations Between Pretherapeutic Imaging and Whole-Body Tumor Dosimetry with Treatment Outcomes.

²²⁵Ac-PSMA-617 in chemotherapy-naive patients with advanced prostate cancer: a pilot study.

Dose evaluation of fast synthetic-CT generation using a generative adversarial network for general pelvis MR-only radiotherapy.

Total-body irradiation using linac-based volumetric modulated arc therapy: Its clinical accuracy, feasibility and reliability.

Does deep inspiration breath-hold prolong life? Individual risk estimates of ischaemic heart disease after breast cancer radiotherapy.

⁶⁸Ga-FAPI PET/CT: Biodistribution and Preliminary Dosimetry Estimate of 2 DOTA-Containing FAP-Targeting Agents in Patients with Various Cancers.

A deep learning-based prediction model for gamma evaluation in patient-specific quality assurance.

Detection Efficacy of ¹⁸F-PSMA-1007 PET/CT in 251 Patients with Biochemical Recurrence of Prostate Cancer After Radical Prostatectomy.

4D robust optimization including uncertainties in time structures can reduce the interplay effect in proton pencil beam scanning radiation therapy.